Cultural Approach to HIV/AIDS Harm Reduction in Muslim Countries

Harm Reduction Journal

Memoona Hasnain¹ 

[1] Department of Family Medicine, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA

关键词: behavioral interventions;    harm reduction;    risk factors;    injection drug users;    HIV;    AIDS;   

Others  :  821535
DOI  :  10.1186/1477-7517-2-23

 received in 2004-11-30, accepted in 2005-10-27,  发布年份 2005

【 摘 要 】

Muslim countries, previously considered protected from HIV/AIDS due to religious and cultural norms, are facing a rapidly rising threat. Despite the evidence of an advancing epidemic, the usual response from the policy makers in Muslim countries, for protection against HIV infection, is a major focus on propagating abstention from illicit drug and sexual practices. Sexuality, considered a private matter, is a taboo topic for discussion. Harm reduction, a pragmatic approach for HIV prevention, is underutilized. The social stigma attached to HIV/AIDS, that exists in all societies is much more pronounced in Muslim cultures. This stigma prevents those at risk from coming forward for appropriate counseling, testing, and treatment, as it involves disclosure of risky practices. The purpose of this paper is to define the extent of the HIV/AIDS problem in Muslim countries, outline the major challenges to HIV/AIDS prevention and treatment, and discuss the concept of harm reduction, with a cultural approach, as a strategy to prevent further spread of the disease. Recommendations include integrating HIV prevention and treatment strategies within existing social, cultural and religious frameworks, working with religious leaders as key collaborators, and provision of appropriate healthcare resources and infrastructure for successful HIV prevention and treatment programs in Muslim countries.

【 授权许可】

   
2005 Hasnain; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Hasnain M, Levy JA: HIV/AIDS. In Encyclopedia of Disability. Volume 2. Edited by Albrecht GA. Thousand Oaks, CA, Sage Publications; 2005::875-883.
• [2]United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO): AIDS epidemic update: 2003. Geneva, Switzerland. [http://www.unaids.org] webcite 2003.
• [3]Buning EC, Coutinho RA, van Brussel GH, van Santen GW, van Zadelhoff AW: Preventing AIDS in drug addicts in Amsterdam. Lancet 1986, 1(8495):1435.
• [4]Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ: Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction 2000, 95(4):591-600.
• [5]Des Jarlais DC, Sotheran JL: The public health paradigm for AIDS and the drug use: shifting the time frame. Br J Addict 1990, 85:348-349.
• [6]Brettle RP: HIV and harm reduction for injection drug users. AIDS 1991, 5(2):125-136.
• [7]Kelley LM, Eberstadt N: Behind the veil of a Ppublic health crisis: HIV/AIDS in the Muslim world. NBP Special Report: The National Bureau of Asian Research. [http://www.aei.org/docLib/20050608_eberstadtNBRreport.pdf] webcite 2005.
• [8]Hasnain M: Antenatal HIV Screening and Treatment in South Africa: Social Norms and Policy Options. Afr J Reprod Health 2004, 8(2):77-85.
• [9]Sigmon M: Africa. Mission Network News. Delivered at the International Coalition for Religious freedom Conference on Religious Freedom and the new millennium. [http://www.icrf.com/conference/DC/sigmon.htm] webcite 2004.
• [10]World Health Organization: The Work of WHO in the Eastern Mediterranean Region. Annual Report of the Regional Director 1 January 31 December 2003. Cairo, World Health Organization Regional Office for the Eastern Mediterranean; 2004.
• [11]Pickthall MM: The Meaning of the Glorious Qur'an. 1930. Hyderabad, India. Chapters and Verses; 17:32, 26:165–166, 5:90
• [12]Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD: Self-reported antiretroviral therapy in injection drug users. JAMA 1998, 280(6):544-546.
• [13]Sherer R: Adherence and antiretroviral therapy in injection drug users. JAMA 1998, 280(6):567-568.
• [14]Holmberg SD: The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996, 86(5):642-654.
• [15]Koester S, Booth RE, Zhang Y: The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12(2):202-207.
• [16]Rhodes T, Stimson GV, Quirk A: Sex, drugs, intervention, and research: from the individual to the social. Subst Use Misuse 1996, 31(3):375-407.
• [17]Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, Koester S, et al.: HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse 1998, 33(12):2403-2423.
• [18]Thorpe LE, Bailey SL, Huo D, Monterroso ER, Ouellet LJ: Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997–1999). J Acquir Immune Defic Syndr 2001, 27(1):71-78.
• [19]Philipson TJ, Posner RA: Private Choices and Public Health. The AIDS Epidemic in an Economic Perspective. Cambridge, MA, Harvard University Press; 1993.
• [20]de Vincenzi I: A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994, 331(6):341-346.
• [21]Padian NS, O'Brien TR, Chang Y, Glass S, Francis DP: Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr 1993, 6(9):1043-1048.
• [22]Farrell M: Condoms and AIDS Prevention: A comparison of three faith-based organizations in Uganda. AIDS and Anthropology Bulletin 2003, 15:3.
• [23]Centers for Disease Control and Prevention International News: Indonesia's Insulation from HIV/AIDS Wears Thin. [http:/ / www.thebody.com/ cdc/ news_updates_archive/ 2003/ jun26_03/ indonesia_aids.html] webciteExcerpted from: Deutsche Presse-Agentur 19/06/03
• [24]Kagimu M, Marum E, Wabwire-Mangen F, Nakyanjo N, Walakira Y, Hogle J: Evaluation of the effectiveness of AIDS health education intervention in the Muslim community in Uganda. AIDS Educ Prev 1998, 10:215-228.
• [25]Meda N, Ndoye I, M'Boup S, Wade A, Ndiaye S, Niang C, Sarr F, Diop I, Carael M: Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention? AIDS 1990, 13(11):1397-1405.
• [26]Lagarde E, Pison G, Enel C: Risk behaviours and AIDS knowledge in a rural community of Senegal: relationship with sources of AIDS information. Int J Epidemiol 1998, 27(5):890-896.
• [27]Fournier AM, Carmichael C: Socioeconomic influences on the transmission of human immunodeficiency virus infection: the hidden risk. Arch Fam Med 1998, 7(3):214-217.
• [28]Hasnain M, Mensah EK, Levy JA, Sinacore JM: Social Capital as a Predictor of HIV/AIDS Risk Behaviors. XIV International AIDS Conference, Barcelona, Spain 2002.
• [29]Hasnain M, Levy JA, Sinacore JM, Mensah EK: Human Capital and HIV Risk in Injection Drug Users. XV International AIDS Conference, Bangkok, Thailand 2004.
• [30]Hasnain M, Sinacore JM, Levy JA, Mensah EK: Influence of Religiosity on HIV Risk Behaviors in Active Injection Drug Users. AIDS Care 2005, 17(7):892-901.
• [31]UNESCO: Mexico City Declaration on Cultural Policies. World Conference on Cultural Policies, Mexico City26 July – 6 August 1982
• [32]UNESCO: A Cultural Approach to HIV/AIDS Prevention and Care. Summary of Country Assessments. An International Overview. In UNESCO/UNAIDS Research Project. Studies and Reports, Special Series. Division of Cultural Policies, UNESCO; 2002.
• [33]Adrien A, Godin G, Cappon P, Singer SM, Maticka-Tyndale E, Willms D: Overview of the Canadian study on the determinants of ethnoculturally specific behaviours related to HIV/AIDS. Can J Public Health 1996, 87(Suppl 1):S4-S10.